Releases from Boots' cost-conscious No7 skincare brand are always highly anticipated but No7’s new Advanced Retinol 1.5% Complex has a record number of people already on its waitlist. In just 10 days, 99,719 eager consumers have signed up to be the first in line for the new product, which represents a shift towards more clinical-grade formulas from the brand.
No7’s Advanced Retinol 1.5% Complex takes the form of a retinol treatment that's formulated to even out the skin tone, plump fine lines and diminish hyperpigmentation. With 0.3% retinol encapsulated within an oil and water base, the skincare treatment is designed to effectively deliver active ingredients to cells without irritation. To further aid with this, the potent serum also contains soothing ingredients.
Image Credit: Boots
Why This Trend Is Growing
- Clinical-grade Formulas
- Opportunity for developing and marketing advanced skincare products with clinical-grade formulas that deliver effective results without irritation.
- Retinol Treatments
- Potential for creating innovative retinol treatments that target skin tone, fine lines, and hyperpigmentation while incorporating soothing ingredients for a comfortable experience.
- Waitlist Marketing
- Disruptive opportunity to utilize waitlists and anticipation to generate buzz and demand for new skincare products.
Industries Being Reshaped
- Skincare
- The skincare industry can benefit from developing clinical-grade formulas and retinol treatments that cater to consumer demands for effective and soothing products.
- Beauty
- Innovation within the beauty industry can be driven by the creation of advanced retinol treatments and marketing strategies that leverage waitlists for heightened demand.
- Cosmetics
- Cosmetic companies can explore disruptive strategies such as creating products with soothing ingredients and leveraging waitlists to create excitement around new releases.
